You are here: Home » News-CM » Companies » Results
Business Standard

Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.14 crore in the December 2019 quarter

Capital Market 

Sales rise 220.00% to Rs 0.16 crore

Net Loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.14 crore in the quarter ended December 2019 as against net loss of Rs 0.04 crore during the previous quarter ended December 2018. Sales rose 220.00% to Rs 0.16 crore in the quarter ended December 2019 as against Rs 0.05 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales0.160.05 220 OPM %-87.50-80.00 -PBDT-0.14-0.04 -250 PBT-0.14-0.04 -250 NP-0.14-0.04 -250

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, February 14 2020. 08:27 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU